Oracle Health Sciences Applications Vulnerability in Life Sciences Central Designer
CVE-2026-21970

6.5MEDIUM

Key Information:

Vendor

Oracle

Vendor
CVE Published:
20 January 2026

What is CVE-2026-21970?

The vulnerability in Oracle Life Sciences Central Designer allows attackers with low privileges and network access via HTTP to exploit the system. This flaw can lead to unauthorized access to sensitive data, potentially compromising the integrity of the application and exposing critical information to malicious actors. The affected version is 7.0.1.0, stressing the need for users to ensure updated security protocols and apply necessary patches to mitigate risks associated with data breaches.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Affected Version(s)

Oracle Life Sciences Central Designer 7.0.1.0

References

CVSS V3.1

Score:
6.5
Severity:
MEDIUM
Confidentiality:
High
Integrity:
None
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

.